Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US68622V1061
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG00ZQRGW24
OGN
Organon & Co
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Drug Manufacturers - General · THEMEFOLIO: $HLTH
NAME
Organon & Co
ISIN
US68622V1061
TICKER
OGN
MIC
XNYS
REUTERS
OGN.N
BLOOMBERG
OGN US
Mo., 14.07.2025       Organon & Co.
US68622V1061

LOS ANGELES, July 14, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. S...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mo., 14.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 14, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to cont...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mo., 14.07.2025       Organon & Co.
US68622V1061

LOS ANGELES, July 14, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the federal securities laws. Shareholders who purchased the Company's securities between October 31, 2024 and April 30, 2025, inclusive (the "Class Period"),...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Sa., 12.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 12, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encou...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Sa., 12.07.2025       Organon & Co.
US68622V1061

NEW ORLEANS, July 11, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 22, 2025 to file lead plaintiff applications in securities class action lawsuits against Organon & Co. (NYSE: OGN), if they purchased the Company's securities between October 31, 2024 and April 30, 2025,...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Fr., 11.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 11, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between November 3, 2022 and April 30, 2025, both dates inclusive (t...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Fr., 11.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Do., 10.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to cont...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mi., 09.07.2025       Organon & Co.
US68622V1061

BENSALEM, Pa., July 9, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ORGANON & CO. (OGN), CONTACT THE L...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mi., 09.07.2025       Organon & Co.
US68622V1061

PHILADELPHIA, July 9, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN) on behalf of purchasers of Organon securities between October 31, 2024 through April 30, 2025, inclusive (the "Class Period")....
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mi., 09.07.2025       Organon & Co.
US68622V1061

SAN DIEGO, July 9, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities between November 3, 2022 and April 30, 2025, inclusive (the "Class Period"). Captioned Lerner v. Organon & C...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mi., 09.07.2025       Organon & Co.
US68622V1061

Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of Organon & Co. (NYSE: OGN) publicly traded securities between November 3, 2022 and April 30, 2025, inclusive (the “Class Period”). Captioned Lerner v. Organon & Co., No. 25-cv-12983 (D.N.J.), the Organon class action la...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Di., 08.07.2025       Organon & Co.
US68622V1061

LOS ANGELES, July 8, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Organon & Co. ("Organon" or the "Company") (NYSE: OGN) have opportunity to lead the securities fraud class action lawsuit....
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Di., 08.07.2025       Organon & Co.
US68622V1061

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Organon To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Organon between October 31, 2024 and April 30, 2025 and would like to discuss your legal rights, call Faruqi &...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Di., 08.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mo., 07.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 7, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encour...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mo., 07.07.2025       Organon & Co.
US68622V1061

LOS ANGELES, July 7, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the federal securities laws. Shareholders...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mo., 07.07.2025       Organon & Co.
US68622V1061

LOS ANGELES, July 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Se...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mo., 07.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 7, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to conta...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mo., 07.07.2025       Organon & Co.
US68622V1061

Organon (NYSE: OGN), a global independent healthcare company with a focus on women’s health, today announced that VTAMA® (tapinarof) cream, 1%, was granted a strong recommendation by the American Academy of Dermatology (AAD) in their 2025 focused guideline update for the management of adults with moderate to severe atopic dermatitis (AD). The reco...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Mo., 07.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 6, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Sa., 05.07.2025       Organon & Co.
US68622V1061

NEW YORK and NEW ORLEANS, July 4, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Organon & Co. (NYSE: OGN), if they purchased...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Do., 03.07.2025       Organon & Co.
US68622V1061

PHILADELPHIA, July 3, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN) on behalf of purchasers of Organon securities between October 31, 2024 through April 30, 2025, inclusive (the "Class Period")....
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Do., 03.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to conta...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Do., 03.07.2025       Organon & Co.
US68622V1061

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Organon between October 31, 2024 and April 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mi., 02.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 2, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encour...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mi., 02.07.2025       Organon & Co.
US68622V1061

Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced that the Phase 2 ELENA proof-of-concept study evaluating the investigational candidate OG-6219 in endometriosis-related pain did not meet its primary efficacy endpoint. OG-6219 is an oral 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) inhibitor, whi...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Di., 01.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 1, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Di., 01.07.2025       Organon & Co.
US68622V1061

NEW YORK, July 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mo., 30.06.2025       Organon & Co.
US68622V1061

LOS ANGELES, June 30, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Organon & Co. ("Organon" or the "Company") (NYSE: OGN)....
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mo., 30.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to cont...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Sa., 28.06.2025       Organon & Co.
US68622V1061

NEW ORLEANS, June 27, 2025 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Organon & Co. (NYSE: OGN), if they purchased the Company's securities between October 31, 2024 and April 30, 2025,...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Fr., 27.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encou...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Fr., 27.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 27, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Fr., 27.06.2025       Organon & Co.
US68622V1061

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Organon To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Organon between October 31, 2024 and April 30, 2025 and would like to discuss your legal rights, call Faruqi...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Do., 26.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 26, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (t...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Do., 26.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 26, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to cont...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mi., 25.06.2025       Organon & Co.
US68622V1061

BENSALEM, Pa., June 25, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ORGANON & CO. (OGN), CONTACT THE...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Di., 24.06.2025       Organon & Co.
US68622V1061

LOS ANGELES, June 24, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Organon & Co. ("Organon" or the "Company") (NYSE: OGN) have opportunity to lead the securities fraud class action lawsuit....
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Di., 24.06.2025       Organon & Co.
US68622V1061

LOS ANGELES, June 24, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the federal securities laws. Shareholders...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Di., 24.06.2025       Organon & Co.
US68622V1061

LOS ANGELES, June 24, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. S...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Di., 24.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Mo., 23.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 23, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to cont...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
So., 22.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encou...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Sa., 21.06.2025       Organon & Co.
US68622V1061

NEW YORK and NEW ORLEANS, June 20, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Organon & Co. (NYSE: OGN), if they purchase...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Fr., 20.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 20, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (th...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Fr., 20.06.2025       Organon & Co.
US68622V1061

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Organon between October 31, 2024 and April 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Fr., 20.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 20, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Do., 19.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to cont...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink
Di., 17.06.2025       Organon & Co.
US68622V1061

NEW YORK, June 17, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encou...
Zur Nachricht
Organon & Co.
Charts & Research Termsheets Terminal
Permalink